IgG ALLOANTIBODY RESPONSES TO DONOR‐SPECIFIC BLOOD TRANSFUSION IN DIFFERENT RAT STRAIN COMBINATIONS AS A PREDICTOR OF RENAL ALLOGRAFT SURVIVAL1,2

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Transplantation

• Publication date

  1992-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199201000-00035PMID 1370737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway

  1991cited by this paper
• IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.

  1991cited by this paper
• The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.

  1991cited by this paper
• Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.

  1990cited by this paper
• HUMORAL IMMUNITY IN ALLOGRAFT REJECTION: THE ROLE OF CYTOTOXIC ALLOANTIBODY IN HYPERACUTE REJECTION AND ENHANCEMENT OF RAT CARDIAC ALLOGRAFTS

  1989cited by this paper
• Transfusion induces blood donor-specific suppressor cells.

  1989cited by this paper
• Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.

  1989cited by this paper
• Recombinant interleukin-2 (IL-2) can reverse the blood transfusion effect.

  1989cited by this paper
• SIMILARITIES IN LONG‐TERM ALLOREACTIVE T CELL LINES PROPAGATED FROM TRANSFUSION ENHANCED AND CONTROL‐REJECTING RAT RENAL ALLOGRAFTS

  1989cited by this paper
• The importance of specificity in the transfusion effect.

  1988cited by this paper
• EVIDENCE THAT PRETRANSPLANT DONOR BLOOD TRANSFUSION PREVENTS RAT RENAL ALLOGRAFT DYSFUNCTION BUT NOT THE IN SITU CELLULAR ALLOIMMUNE OR MORPHOLOGIC MANIFESTATIONS OF REJECTION12

  1988cited by this paper
• EFFECT OF BLOOD TRANSFUSION ON IL‐2 PRODUCTION

  1988cited by this paper
• IMPROVED RENAL ALLOGRAFT SURVIVAL FOLLOWING DONOR‐SPECIFIC TRANSFUSIONS: III. Kinetics of Mixed Lymphocyte Culture Responses Before and After Transplantation1

  1988cited by this paper
• TWO PATTERNS OF SENSITIZATION DEMONSTRATED BY RECIPIENTS OF DONOR‐SPECIFIC TRANSFUSION LIMITATIONS TO CONTROL BY IMURAN

  1987cited by this paper
• Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats

  1987cited by this paper
• FAILURE OF DONOR‐SPECIFIC PRETRANSPLANT BLOOD TRANSFUSION TO PROLONG HETEROTOPIC CARDIAC ALLOGRAFT SURVIVAL IN RATS

  1987cited by this paper
• Use of the Donor Specific Transfusion Protocol in Living‐Unrelated Donor‐Recipient Combinations

  1986cited by this paper
• The alloantibody response in the allogeneically pregnant rat. IV. Analysis of the alloantibody specificities with monoclonal antibodies.

  1986cited by this paper
• Suppressor T cells in allogeneic models.

  1986cited by this paper
• Functional role of thromboxane production by acutely rejecting renal allografts in rats.

  1985cited by this paper
• Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

  1984cited by this paper
• The alloantigenic organization of RT1Aa, a class I major histocompatibility complex molecule of the rat

  1984cited by this paper
• Use of biotin-labeled monoclonal antibodies and avidin-peroxidase conjugates for the determination of epitope specificities in a solid-phase competitive enzyme immunoassay.

  1984cited by this paper
• VARIABLE RESPONSE TO DONOR‐SPECIFIC BLOOD TRANSFUSION IN THE RAT

  1984cited by this paper
• Genetics of the blood transfusion effect on heart allografts in rats.

  1984cited by this paper
• Prolongation of rat cardiac allografts by pretransplant administration of blood transfusions and cyclosporin A.

  1982cited by this paper
• Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex- linked defect for antibody responses to class I alloantigens

  1982cited by this paper
• The alloantibody response in the allogeneically pregnant rat. I. The primary and secondary responses and detection of Ir gene control.

  1982cited by this paper
• Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach

  1980cited by this paper
• Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG

  1979cited by this paper
• The effect of anticomplementary cobra venom factor on hyperacute rat cardiac allograft rejection.

  1978cited by this paper
• The reactivity of blood lymphocytes from actively enhanced rats.

  1973cited by this paper
• THE EFFECT OF DONOR STRAIN BLOOD PRETREATMENT ON RENAL ALLOGRAFT REJECTION IN RATS

  1972cited by this paper
• Specific inhibition of organ allograft rejection by donor blood.

  1971cited by this paper

• Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria.

  2019cites this paper
• Role of the liver in determining alloimmune response in vitro following donor-specific spleen cell injection.

  2010cites this paper
• Treatment With Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants

  2007cites this paper
• Contribution à l’analyse des mécanismes impliqués dans le maintien de la tolérance induite par transfusion spécifique de sang du donneur

  2006cites this paper
• Antibody and Complement Mediated Injury in Transplants Following Sensitization by Allogeneic Blood Transfusion

  2006cites this paper
• Prolonged cold‐preservation of nerve allografts

  2005cites this paper
• Terminal Complement Components Mediate Release of von Willebrand Factor and Adhesion of Platelets in Arteries of Allografts

  2005cites this paper
• Role of B Lymphocytes and Alloantibodies in Organ Transplantation

  2004cites this paper
• Regulatory cell-mediated tolerance does not protect against chronic rejection

  2003cites this paper
• FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts

  2003cites this paper
• The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance

  2003cites this paper
• The effect of FTY 720 on engraftment in a model of spontaneous allograft acceptance

  2003cites this paper
• Induction of tolerance by donor-specific blood transfusion in a model of intestinal transplantation: technical and immunological aspects.

  2002cites this paper
• CTLA 4 Ig Inhibits Alloantibody Responses to Repeated Blood Transfusions By

  2002cites this paper
• The Biology of Major Histocompatibility Complex Molecules—I

  2000cites this paper
• Chronic allograft dysfunction: mechanisms and new approaches to therapy.

  2000cites this paper
• Complement as a mediator of allograft injury: an inflammatory view

  2000cites this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine.

  2000cites this paper
• Complement as a mediator of vascular inflammation and activation in allografts.

  2000cites this paper
• Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.

  2000cites this paper
• Persisting alloantigen prevents primed CD45RC − CD4 T cells from inducing allograft rejection: implications for immunological memory

  1999cites this paper
• Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.

  1998cites this paper
• Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.

  1998cites this paper
• Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.

  1998cites this paper
• Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.

  1998cites this paper
• Importance of T cells to accelerated rejection and acceptance of renal allografts in sensitized rat recipients.

  1998cites this paper
• Malononitrilamides 715 and 279 Prolong Rat Cardiac Allograft Survival, Reverse Ongoing Rejection, Inhibit Allospecific Antibody Production and Interact Positively with Cyclosporin

  1998cites this paper
• Malononitrilamides reduce IgM and IgG xenoantibodies and prolong skin xenograft survival in a mouse-to rat model.

  1998cites this paper
• CONTRASTING OUTCOMES OF DONOR-SPECIFIC BLOOD TRANSFUSION

  1998cites this paper
• Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.

  1997cites this paper
• The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model.

  1997cites this paper
• CTLA4Ig inhibits alloantibody responses to repeated blood transfusions.

  1996cites this paper
• The Facilitating Effect Of One‐Dr Antigen Sharing In Renal Allograft Tolerance Induced By Donor Bone Marrow In Rhesus Monkeys

  1995cites this paper
• Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.

  1995cites this paper
• Complement in organ transplantation. Contributions to inflammation, injury, and rejection.

  1995cites this paper
• Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.

  1994cites this paper
• Effect of liposomal methylprednisolone on heart allograft survival and immune function in rats.

  1994cites this paper
• ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL ADHESION1,2

  1994cites this paper
• Veto cells in transplantation tolerance 1

  1994cites this paper
• Veto Cells and the Induction of Transplant Tolerance in Primates

  1994cites this paper
• Serial analysis of cytokines, adhesion molecule expression, and humoral responses during development of chronic kidney allograft rejection in a new rat model.

  1993cites this paper
• Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.

  1993cites this paper
• Experimental renal transplantation: IgG antibodies which bind to graft tubular epithelial cells cannot be detected in the serum of recipient rats after pre-operative transfusion of donor blood.

  1993cites this paper
• Delayed elimination of donor red blood cells is associated with host major histocompatibility complex and donor-specific blood transfusion enhancement of rat renal allograft survival.

  1993cites this paper
• THE ASSOCIATION OF ENHANCEMENT OF RENAL ALLOGRAFT SURVIVAL BY DONOR‐SPECIFIC BLOOD TRANSFUSION WITH HOST MHC‐LINKED INHIBITION OF IgG ANTI‐DONOR CLASS I ALLOANTIBODY RESPONSES

  1993cites this paper
• CYTOKINES, ADHESION MOLECULES, AND THE PATHOGENESIS OF CHRONIC REJECTION OF RAT RENAL ALLOGRAFTS

  1993cites this paper
• Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.

  1993cites this paper